We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+14.61%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$51.6B
AUM Growth
+$5.68B
Cap. Flow
-$429M
Cap. Flow %
-0.83%
Top 10 Hldgs %
17.19%
Holding
3,020
New
40
Increased
1,307
Reduced
1,586
Closed
73

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$73.8M
2
AMZN icon
Amazon
AMZN
+$68.6M
3
AAPL icon
Apple
AAPL
+$64.9M
4
MSFT icon
Microsoft
MSFT
+$61.4M
5
META icon
Meta Platforms (Facebook)
META
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 15.13%
3 Healthcare 13.65%
4 Consumer Discretionary 10.39%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIZ icon
2701
First Business Financial Services
FBIZ
$601M
$224K ﹤0.01%
11,187
-160
-1% -$3.38K
BOCH
2702
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$224K ﹤0.01%
21,251
-90
-0.4% -$996
PETX
2703
DELISTED
Aratana Therapeutics, Inc.
PETX
$224K ﹤0.01%
62,288
+677
+1% +$2.93K
CRNX icon
2704
Crinetics Pharmaceuticals
CRNX
$8.91B
$223K ﹤0.01%
9,776
+1,301
+15% +$32K
KOPN icon
2705
Kopin
KOPN
$732M
$223K ﹤0.01%
166,205
-1,525
-0.9% -$2.04K
RVSB icon
2706
Riverview Bancorp
RVSB
$109M
$222K ﹤0.01%
30,381
+642
+2% +$4.84K
PVLA
2707
Palvella Therapeutics
PVLA
$2.22B
$221K ﹤0.01%
824
-11
-1% -$2.61K
HALL
2708
DELISTED
Hallmark Financial Services, Inc.
HALL
$221K ﹤0.01%
2,125
-8
-0.4% -$818
TYME
2709
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$221K ﹤0.01%
125,460
-2,010
-2% -$5.26K
CNST
2710
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$221K ﹤0.01%
+16,312
New +$146K
EML icon
2711
Eastern Company
EML
$147M
$219K ﹤0.01%
+7,975
New +$217K
NODK icon
2712
NI Holdings
NODK
$315M
$219K ﹤0.01%
13,699
-70
-0.5% -$1.08K
AMAL icon
2713
Amalgamated Financial
AMAL
$1.5B
$218K ﹤0.01%
13,951
+1,275
+10% +$22.9K
STRS icon
2714
Stratus Properties
STRS
$159M
$218K ﹤0.01%
+8,269
New +$204K
PRTK
2715
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$216K ﹤0.01%
40,338
-860
-2% -$5.55K
SLCT
2716
DELISTED
Select Bancorp, Inc.
SLCT
$216K ﹤0.01%
18,995
+2,663
+16% +$31.4K
GPX
2717
DELISTED
GP Strategies Corp.
GPX
$216K ﹤0.01%
17,788
-210
-1% -$3.06K
CRR
2718
DELISTED
Carbo Ceramics Inc.
CRR
$216K ﹤0.01%
61,712
-821
-1% -$3.44K
ESSA
2719
DELISTED
ESSA Bancorp
ESSA
$215K ﹤0.01%
13,939
+366
+3% +$5.77K
LCNB icon
2720
LCNB Corp
LCNB
$281M
$215K ﹤0.01%
12,552
-182
-1% -$3.02K
CVIA
2721
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$215K ﹤0.01%
38,436
-1,196
-3% -$6.16K
PRGX
2722
DELISTED
PRGX Global, Inc.
PRGX
$214K ﹤0.01%
27,008
+375
+1% +$3.35K
PFNX
2723
DELISTED
Pfenex Inc.
PFNX
$214K ﹤0.01%
34,667
+746
+2% +$3.27K
ATHX
2724
DELISTED
Athersys, Inc. Common Stock
ATHX
$213K ﹤0.01%
5,676
-94
-2% -$3.6K
AMPY icon
2725
Amplify Energy
AMPY
$160M
$212K ﹤0.01%
21,750
-183
-0.8% -$1.7K

Similar funds

RhumbLine Advisers's Q1 2019 Portfolio in Review

As of Q1 2019, RhumbLine Advisers held 3,020 positions worth $51.6B, up 12% from $46B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 3.7%. RhumbLine Advisers opened 40 new positions and exited 73, leaving the 3,020-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2019 buy was Fox Class A: 602,636 shares worth $22.1M.
  • RhumbLine Advisers added most to Walt Disney in Q1 2019, an estimated $73.8M increase.
  • RhumbLine Advisers's biggest Q1 2019 reduction was Wells Fargo, cutting an estimated $16.4M.
  • RhumbLine Advisers fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $89.7M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $51.6B portfolio in Q1 2019.
  • RhumbLine Advisers opened 40 new positions and closed 73 in Q1 2019.
  • RhumbLine Advisers's portfolio value rose 12% quarter-over-quarter to $51.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2019, filed 1 May 2019.